BFC Planning’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.56K Sell
209
-49
-19% -$1.43K ﹤0.01% 2721
2026
Q2
$9.34K Buy
258
+34
+15% +$1.16K ﹤0.01% 2403
2026
Q1
$7.41K Hold
224
– – ﹤0.01% 2155
2025
Q4
$10.4K Buy
224
+15
+7% +$628 ﹤0.01% 2063
2025
Q3
$7.31K Hold
209
– – ﹤0.01% 2058
2025
Q2
$6.18K Sell
209
-262
-56% -$7.47K ﹤0.01% 1984
2025
Q1
$14.1K Hold
471
– – ﹤0.01% 1617
2024
Q4
$13.5K Hold
471
– – ﹤0.01% 1632
2024
Q3
$18.2K Buy
+471
New +$16.8K ﹤0.01% 1494

Other funds holding COLL

BFC Planning's COLL Position: Q3 2026 in Review

BFC Planning reduced its Collegium Pharmaceutical (COLL) stake by 19% in Q3 2026, selling an estimated $1.43K and leaving 209 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

BFC Planning first reported a position in COLL in Q3 2024 and has held it in 9 quarters since. The position peaked at $18.2K in Q3 2024. 188 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • BFC Planning held 209 shares of Collegium Pharmaceutical worth $4.56K as of Q3 2026.
  • BFC Planning sold 49 Collegium Pharmaceutical shares in Q3 2026, an estimated $1.43K.
  • Collegium Pharmaceutical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2721 holding.
  • BFC Planning first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Collegium Pharmaceutical position peaked at $18.2K in Q3 2024.
  • 188 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.